Search results
Psychedelic stocks tanked after MDMA-assisted therapy for PTSD had a setback
Quartz· 2 days agoThe stock moves come after the FDA’s Psychopharmacologic Drugs Advisory Committee reviewed a new...
Psychedelic stocks fall as MDMA drug rejected (NASDAQ:MNMD)
Seeking Alpha· 2 days agoDevelopers of psychedelic drugs sold off in the premarket after an FDA panel voted against marketing...
Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment By...
Investing.com· 2 days agoPsychedelic stocks declined Wednesday after advisers to the U.S. Food and Drug Administration failed...
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment - ATAI Life Sciences...
Benzinga· 2 days agoA panel of advisors to the Food and Drug Administration (FDA) rejected MDMA as a treatment for...
Psychedelic-medicine stocks drop after ecstasy’s rocky day at the FDA
Market Watch· 2 days agoPsychedelic-medicine stocks dropped sharply early Wednesday, a day after an independent panel of...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
FOX 4 Kansas City· 3 days agoWASHINGTON (AP) — Federal health advisers are weighing the first-of-a-kind approval of MDMA, the...
The Case for MDMA’s Approval Is Riddled With Problems
Wired News· 15 hours agoThe results sounds promising, but Michael Ostacher, a professor of psychiatry and behavioral ...
Magic Mushrooms Get Canadian Export License in Psychedelic Race
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Canada has licensed a startup to export psychedelics to Australia for patient use,...
Panel rejects psychedelic drug MDMA as a PTSD treatment in setback for advocates
Los Angeles Times· 2 days agoFederal health advisers voted Tuesday against a first-of-a-kind proposal to use the mind-altering...
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
WCTV Tallahassee· 7 days agoFederal health regulators are questioning the safety and evidence behind the first bid to use MDMA,...